Anti-Counterfeiting for

Pharmaceuticals and Nutraceuticals

Anti-Counterfeiting for
Pharmaceuticals and Nutraceuticals

Authenticate the Product, not just the Packaging

Touching nearly every therapeutic class, counterfeit medications total $200 billion annually. The World Health Organization estimates that up to 50% of online medicines could be fake. Additionally, counterfeit nutraceuticals pose a serious threat to consumers as more than 50% of FDA Class I recalls between 2004 and 2012 were for dietary supplements. Product security stops at the unit of sale level, enabling significant risk of fraud, adulteration, and diversion during manufacturing and distribution.

The Solution: miniDART™

The miniDART delivers on-dose traceability with safe, edible, invisible DNA barcodes (FDA-GRAS). Manufacturers generate CoA machine-readable barcodes that are mixed with coating or ingredients during regular pharmaceutical and nutraceutical production. In turn, downstream supply chain partners can verify the authenticity, origin, and safety of a dose or its ingredients within 25 minutes more accurately and reliably than with traditional packaging-based serialization.

Use Cases and Benefits

Add immutable on-product security to high-end nutraceutical and active pharmaceutical ingredients (APIs) and finished products to quickly identify counterfeits, packaging, and trademark infringement:

  • Reduce in-house manufacturing costs by streamlining QC testing of APIs and excipients
  • Eliminate price arbitrage by clearly linking each dose to its source and preventing diversion to illicit markets
  • Protect revenue and brand reputation by reducing likelihood, scale, and response time of product recalls
  • Strengthen saleable returns processes with on-dose traceability for accurate and cost-effective verification
  • Improve patient protection and treatment monitoring by verifying dose-level safety as part of routine or exception handling prior to dispensing
Buy now